1582
Helvetica Chimica Acta – Vol. 94 (2011)
7-Methyl-2-phenyl-4H-[1,3]thiazolo[3,2-a][1,3,5]triazine-4-selone (13d). From 878 mg (3.4 mmol)
of 1a and 388 mg (3.4 mmol) of 10b. Yield: 0.60 g (58%). Orange crystals. M.p. 280 – 2818 (acetone/
DMF). IR (KBr): 3101w, 3053w, 3031w, 2967w, 1587m, 1518vs, 1492m, 1456s, 1401vs, 1384vs, 1341s, 1326s,
1298m, 1273m, 1256s, 1182m, 1137m, 1100m, 1080m, 1021w, 996w, 941w, 879m, 838s, 807m, 743s, 693m.
1H-NMR (300 MHz, CDCl3): 8.66 (q-like, J ¼ 1.4, 1 H); 8.56 – 8.54 (m, 2 arom. H); 7.62 – 7.51 (m, 1 arom.
H); 7.49 – 7.46 (m, 2 arom. H); 2.53 (d, J ¼ 1.4, Me). 13C-NMR (75 MHz, CDCl3): 178.7 (s, C¼Se); 167.1,
160.0 (2s, C(2), C(8a)); 133.9, 127.1 (2s, 1 arom. C, C(7)); 133.4, 130.4, 128.7 (3d, 5 arom. CH); 126.8 (d,
C(6)); 13.5 (q, Me). EI-MS: 309 (12), 308 (8), 307 (55, Mþ), 305 (27), 304 (10), 303 (9), 202 (13), 201
(100), 198 (15), 197 (14). Anal. calc. for C12H9N3SSe (306.25): C 47.06, H 2.96, N 13.72, S 10.47; found: C
46.99, H 2.83, N 13.85, S 10.63.
7-Methyl-2-(4-methylphenyl)-4H-[1,3]thiazolo[3,2-a][1,3,5]triazine-4-selone (13e). From 1.376 g
(4.6 mmol) of 1b and 524 mg (4.6 mmol) of 10b. Yield: 0.93 g (63%). Orange-yellow crystals. M.p.
2918 (dec.; DMF). IR (KBr): 3074m, 2933w, 1606w, 1589m, 1573w, 1530vs, 1508s, 1456m, 1420s, 1393vs,
1359s, 1333s, 1298s, 1275s, 1257s, 1179m, 1140s, 1111m, 1100m, 1018w, 992w, 877m, 848s, 852w, 836s, 764s.
CI-MS: 324 (21), 323 (15), 322 (100, [M þ 1]þ), 321 (8), 320 (49), 319 (17), 318 (17), 258 (7). Anal. calc.
for C13H11N3SSe (320.28): C 48.75, H 3.46, N 13.12, S 10.01; found: C 48.58, H 3.37, N 13.07, S 10.11.
2-(4-Chlorophenyl)-7-methyl-4H-[1,3]thiazolo[3,2-a][1,3,5]triazine-4-selone (13f). From 991 mg
(3.1 mmol) of 1c and 353 mg (3.1 mmol) of 10b. Yield: 0.65 g (62%). Orange crystals. M.p. 282.0 –
1
282.58 (DMF). H-NMR (300 MHz, CDCl3): 8.65 (q-like, J ¼ 1.4, 1 H); 8.50, 7.46 (AA’BB’, JAB ¼ 8.7, 4
arom. H); 2.54 (d, J ¼ 1.4, Me). 13C-NMR (75 MHz, CDCl3): 179.0 (s, C¼Se); 168.0, 158.0 (2s, C(2),
C(8a)); 140.2, 132.2, 127.5 (3s, 2 arom. C, C(7)); 131.5, 129.0 (2d, 4 arom. CH); 126.7 (d, C(6)); 13.4 (q,
Me). EI-MS: 343 (17), 342 (6), 341 (38, Mþ), 340 (5), 339 (17), 338 (6), 337 (6), 268 (23), 253 (45), 237
(37), 236 (12), 235 (100). Anal. calc. for C12H8ClN3SSe (340.69): C 42.31, H 2.37, N 12.33, S 9.41; found: C
42.10, H 2.29, N 12.26, S 9.27.
4. Reaction of 1c with 2-Amino-3-methylpyridine (11). To a stirred soln. of 1c (992 mg, 3.1 mmol) in
acetone (20 ml) at r.t., 1 equiv. of 11 (335 mg, 3.1 mmol) was added, and the mixture was stirred for 3 h,
until the starting materials were completely consumed (TLC). Then, the mixture was poured into H2O
and stirred for another 1 h. The yellowish precipitate was filtered under vacuum and recrystallized from
Et2O to give 0.85 g (64%) of 2-(4-chlorophenyl)-9-methyl-3-phenyl-3H-4l4-[1,2,4]selenadiazolo-
[1’,5’:1,5][1,2,4]selenadiazolo[2,3-a]pyridine (14). M.p. 189.5 – 190.5. IR: 3041w, 2955w, 2948w, 1605w,
1592w, 1567w, 1511s, 1463s, 1445m, 1401s, 1367vs, 1319m, 1300m, 1286s, 1274s, 1223m, 1196s, 1125m,
1
1104m, 1089m, 1071w, 1015m, 992w, 951m, 892w, 838m, 778m, 765w, 748m, 734m. H-NMR (300 MHz,
CDCl3): 8.24 (dd-like, J ¼ 8.7, 0.8, 1 H); 7.63 – 7.54 (m, 3 H); 7.35 – 7.20 (m, 5 H); 7.08 – 7.04 (m, 2 H); 6.84
(dd-like, J ¼ 7.0, 5.8, 1 H); 2.64 (s, Me). 13C-NMR (75 MHz, CDCl3): 174.4 (s, C¼Se); 162.2, 156.4, 141.2,
136.2, 131.0, 130.5 (6s, 3 arom. C, 3 C); 137.0, 135.0, 126.2, 115.4 (4d, 1 arom. CH, 3 CH); 131.5, 129.3,
128.1, 125.5 (4d, 8 arom. CH); 17.5 (q, Me). CI-MS: 430 (5), 429 (38), 428 (19), 427 (100, [M þ 1]þ), 426
(13), 425 (46), 424 (15), 423 (15), 349 (14), 347 (25), 233 (13), 231 (41), 136 (7), 134 (12). Anal. calc. for
C20H15ClN4Se (425.78): C 56.42, H 3.55, N 13.16, Cl 8.33; found: C 56.00, H 3.66, N 12.97, Cl 8.50.
Suitable crystals for the X-ray crystal-structure determination were obtained from Et2O/AcOEt.
5. Reactions of 1 with 1-Methyl-1H-imidazole (12). To a soln. of 1b (987 mg, 3.3 mmol) or 1c
(895 mg, 2.8 mmol) in acetone (30 ml), 1 equiv. of 12 (271 and 230 mg, resp.) was added, and the mixture
was stirred at r.t. overnight. TLC indicated that the starting materials were completely consumed. Then,
the mixture was poured into ice/H2O and stirred for another 2 h. The yellowish precipitate was filtered
under vacuum and recrystallized from AcOEt.
3-Methyl-1-[(Z)-(4-methylphenyl)(phenylimino)methyl]-1H-imidazol-3-ium Selenocyanate (15b).
Yield: 0.66 g (52%). Pale yellow crystals. M.p. 116.5 – 117.58 (AcOEt). IR: 3181w, 3083m, 2061vs, 1654s,
1608m, 1583s, 1537s, 1509w, 1484m, 1449w, 1417m, 1333s, 1272m, 1233s, 1211m, 1189m, 1143s, 1088m,
1
1023w, 927s, 907w, 831m, 794w, 766m, 727m, 695s. H-NMR (600 MHz, CDCl3): 9.30 (br. s, HꢀC(2));
7.78 – 7.76, 7.74 – 7.72 (2m, 2 H); 7.33 – 7.27 (m, 2 arom. H); 7.27 – 7.15 (m, 4 arom. H); 7.12 – 7.02 (m, 1
arom. H); 6.84 – 6.78 (m, 2 arom. H); 4.19 (s, MeN); 2.36 (s, Me). 13C-NMR (150 MHz, CDCl3): 148.7 (s,
C¼N); 145.2, 142.8, 123.8 (3s, 3 arom. C); 136.9 (d, C(2)); 130.2, 129.6, 129.0, 121.2 (4d, 2 arom. CH
each); 125.5 (d, 1 arom. CH); 124.5, 119.8 (2d, C(4), C(5)); 117.6 (s, NCSe); 37.7 (q MeN); 21.5 (q, Me).